MedTrace Logo

Adaptive Radiotherapy for Head and Neck Cancer

NCT03096808 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-10-26

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that adaptive radiotherapy (ART) in head and neck cancer patients are comparable to historical controls in head and neck patients undergoing standard intensity-modulated radiation therapy (IMRT) without ART.

Conditions

  • Head and Neck Cancer
  • Paranasal Sinus Cancer
  • Oropharynx Cancer
  • Oral Cavity Cancer
  • Nasopharynx Cancer
  • Larynx Cancer
  • Hypopharynx Cancer

Interventions

RADIATION

Adaptive Radiotherapy

ART involved modification of the radiation treatment plan during treatment course to account for temporal variations in anatomy due to changes in tumor volume and/or patients' weight loss.

Sponsors & Collaborators

Principal Investigators

  • C. Jillian Tsai, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2021-10-22
Completion
2021-10-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096808 on ClinicalTrials.gov